ArticlePharmaceuticals (Basel, Switzerland)2026
Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.
Laura García-Quintanilla, Pablo Almuiña-Varela, María José Rodríguez-Cid, María Gil-Martinez, Maximino J Abraldes, Francisco Gomez-Ulla, Miguel González-Barcia, Diana Carolina Castro-Fernández, Antonio Cañizo-Outeiriño, Andrea Cuartero-Martínez and 4 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Laura García-QuintanillaHospital Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
Pablo Almuiña-VarelaFarmaCHUSLab Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-4186-641X María José Rodríguez-CidOphthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
María Gil-MartinezOphthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
Maximino J AbraldesOphthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0001-8100-5433 Francisco Gomez-UllaInstituto Oftalmológico Gómez-Ulla, 15706 Santiago de Compostela, Spain.
Miguel González-BarciaHospital Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
Diana Carolina Castro-FernándezFarmaCHUSLab Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0009-0009-5281-5694 Antonio Cañizo-OuteiriñoHospital Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0009-0003-2492-0266 Andrea Cuartero-MartínezFarmaCHUSLab Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
Ana Estany-GestalFIDIS-Unidad de Epidemiología e Investigación Clínica, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-7997-3603 Francisco J Otero-EspinarDepartment of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain.ORCID 0000-0001-9030-2253 Maribel Fernández-RodríguezOphthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0001-5675-9356 Anxo Fernández-FerreiroHospital Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-7348-7337 Funding
Instituto de Salud Carlos III PI17/00940Instituto de Salud Carlos III PI23/00069Xunta de Galicia IN607A2023/04Xunta de Galicia IN607D 2021/001
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
age-related macular degenerationinflammatoryranibizumab
Identifiers
PMID42356572
PMCPMC13304664
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390